Chengdu Olymvax Biopharmaceuticals Inc.

Informe acción SHSE:688319

Capitalización de mercado: CN¥4.2b

Chengdu Olymvax Biopharmaceuticals Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Shaowen Fan

Chief Executive Officer (CEO)

CN¥713.5k

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO14.8yrs
Participación del CEO3.9%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directiva8.4yrs

Actualizaciones recientes de la dirección

Recent updates

Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319) Stock Rockets 40% As Investors Are Less Pessimistic Than Expected

Oct 09
Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319) Stock Rockets 40% As Investors Are Less Pessimistic Than Expected

We Think Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Has A Fair Chunk Of Debt

Sep 30
We Think Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Has A Fair Chunk Of Debt

What Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) 26% Share Price Gain Is Not Telling You

Jun 24
What Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) 26% Share Price Gain Is Not Telling You

Is There An Opportunity With Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) 27% Undervaluation?

May 28
Is There An Opportunity With Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) 27% Undervaluation?

Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319) Shares May Have Slumped 25% But Getting In Cheap Is Still Unlikely

Apr 18
Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319) Shares May Have Slumped 25% But Getting In Cheap Is Still Unlikely

These 4 Measures Indicate That Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Is Using Debt Extensively

Mar 26
These 4 Measures Indicate That Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Is Using Debt Extensively

CEO

Shaowen Fan (71 yo)

14.8yrs

Permanencia

CN¥713,500

Compensación

Mr. Shaowen Fan is Chairman of the Board & GM of Chengdu Olymvax Biopharmaceuticals Inc. from January 2010. Mr. Fan joined the Chengdu Olymvax Biopharmaceuticals Inc. in 2010.


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Shaowen Fan
Chairman of the Board & GM14.8yrsCN¥713.50k3.86%
CN¥ 161.1m
Yunhui Yu
Director11.4yrsCN¥42.00k0.014%
CN¥ 575.9k
Pengfei Zhang
Chairman of Supervisory Board8.4yrssin datos6.38%
CN¥ 266.2m
Fan Fan
Executive Deputy GM & Vice Chairman of the Board14.8yrsCN¥633.20k7.53%
CN¥ 314.3m
Cheng Hu
Director2.5yrsCN¥42.00k1.64%
CN¥ 68.5m
Aimin Chen
Director14.8yrsCN¥602.00k0.15%
CN¥ 6.3m
Lu Lu
Employee Representative Director2.5yrsCN¥195.00k0.067%
CN¥ 2.8m
Shao Ping He
Independent Director5.6yrsCN¥83.90ksin datos
Hua Yan
Supervisor2.5yrssin datos0.20%
CN¥ 8.4m

8.4yrs

Permanencia media

61yo

Promedio de edad

Junta con experiencia: La junta directiva de 688319 se considera experimentada (8.4 años de antigüedad promedio).